Zobrazeno 1 - 10
of 73
pro vyhledávání: '"R M Bukowski"'
Autor:
R M Bukowski, M Zhou, Robert M. Gemmill, Luciano J. Costa, Christopher Korch, Harry A. Drabkin
Publikováno v:
British Journal of Cancer
Epidermal growth factor receptor (EGFR) and tumour growth factor alpha (TGFalpha) are frequently overexpressed in renal cell carcinoma (RCC) yet responses to single-agent EGFR inhibitors are uncommon. Although von Hippel-Lindau (VHL) mutations are pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d7244249f371fe05b8fcdd4b5ad273
http://europepmc.org/articles/PMC2361810
http://europepmc.org/articles/PMC2361810
Publikováno v:
AIDS Patient Care and STDs. 10:299-302
Eighty-two male transvestites imprisoned in Casa de Detenção (São Paulo, Brazil) were tested for HIV antibodies, and completed a questionnaire investigating their demographics, arrest and imprisonment records, sexual practices, and drug use. Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c11d7b2777ef2804115f7d3786aacbc
https://doi.org/10.1089/apc.1996.10.299
https://doi.org/10.1089/apc.1996.10.299
Autor:
R. M. Bukowski
Publikováno v:
Cleveland Clinic Journal of Medicine. 62:S1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e91fca593d83ae83f86c6167c44ea108
https://doi.org/10.3949/ccjm.62.s1.5
https://doi.org/10.3949/ccjm.62.s1.5
Autor:
R. M. Bukowski, S. A. Murthy, J. Finke, M. J. Caulfield, R. Tubbs, P. Herzog, W. Stanley, M. Edinger, L. Tuason, D. McLain, G. T. Budd, T. Olencki, R. Ganapathi
Publikováno v:
Journal of Immunotherapy. 15:273-282
The therapeutic and biologic effects of murine monoclonal antibodies in patients with malignancies have been widely investigated. Attempts to enhance results by combining these agents with cytotoxic drugs are now under study. A Phase I trial was perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed7d6cad11a4bac7bb3522e0bfb5b570
https://doi.org/10.1097/00002371-199405000-00006
https://doi.org/10.1097/00002371-199405000-00006
Autor:
R. M. Bukowski
Publikováno v:
Cleveland Clinic Journal of Medicine. 64:S1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6fd883f009f58d0b034212350663b48
https://doi.org/10.3949/ccjm.64.s1.3
https://doi.org/10.3949/ccjm.64.s1.3
Autor:
Wolff Schmiegel, Paulo M. Hoff, J Lokich, Edith P. Mitchell, P Dufour, J. Schoelmerich, David Cunningham, Ullrich Graeven, G. Perez-Manga, Alberto Sobrero, R M Bukowski, S Madajewicz, Richard L. Schilsky, Peter Harper, Jean A. Maroun, E. Van Cutsem, John L. Marshall, Ph. Rougier
Publikováno v:
British Journal of Cancer
This study evaluates the efficacy of capecitabine using data from a large, well-characterised population of patients with metastatic colorectal cancer (mCRC) treated in two identically designed phase III studies. A total of 1207 patients with previou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ad4677e1ec4f0ac9d0aaf4c9d00098
http://hdl.handle.net/11390/851180
http://hdl.handle.net/11390/851180
Autor:
R M, Bukowski
Publikováno v:
Seminars in urologic oncology. 19(2)
Cytokine therapy for patients with metastatic renal cancer is based on observations suggesting this neoplasm may be responsive to immunotherapy. Two cytokines, interferon-alpha (IFN-alpha) and interleukin 2 (IL-2) produce tumor regressions in 10% to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d49550bc9be5090e235ad9d5e217d11
https://pubmed.ncbi.nlm.nih.gov/11354535
https://pubmed.ncbi.nlm.nih.gov/11354535
Autor:
J H, Finke, P, Rayman, R, George, C S, Tannenbaum, V, Kolenko, R, Uzzo, A C, Novick, R M, Bukowski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
Antitumor immunity fails to adequately develop in many cancer patients, including those with renal cell carcinoma (RCC). A number of different mechanisms have been proposed to explain the immune dysfunction observed in cancer patient T cells. Here we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::690827e6ec1967884bb8f6047a892adf
https://pubmed.ncbi.nlm.nih.gov/11300495
https://pubmed.ncbi.nlm.nih.gov/11300495
Autor:
R M, Bukowski
Publikováno v:
Seminars in oncology. 27(2)
Treatment of metastatic renal cell carcinoma (RCC) remains unsatisfactory. To enhance the antitumor effects of various cytokines, combinations of these agents have been investigated. Interleukin-2 (IL-2) and interferon-alfa (IFN-alpha) have been comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a95925955baf3868a161c0baa325e7dc
https://pubmed.ncbi.nlm.nih.gov/10768599
https://pubmed.ncbi.nlm.nih.gov/10768599
Autor:
P, Rayman, R G, Uzzo, V, Kolenko, T, Bloom, M K, Cathcart, L, Molto, A C, Novick, R M, Bukowski, T, Hamilton, J H, Finke
Publikováno v:
The cancer journal from Scientific American. 6
The development of an effective antitumor immune response is compromised in patients with renal cell carcinoma. Despite significant infiltration by T lymphocytes into renal tumors, no detectable induction of gene expression is associated with the gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ee5d3256adc479a0fe0173187265cd6
https://pubmed.ncbi.nlm.nih.gov/10685665
https://pubmed.ncbi.nlm.nih.gov/10685665